4.7 Article Proceedings Paper

Defining Long-term Outcomes With Living Donor Liver Transplantation in North America

Journal

ANNALS OF SURGERY
Volume 262, Issue 3, Pages 465-475

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0000000000001383

Keywords

Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL); deceased donor liver transplant; dialysis; graft survival; living donor liver transplant

Categories

Funding

  1. NCATS NIH HHS [UL1 TR001082] Funding Source: Medline
  2. NIDDK NIH HHS [U01 DK085515, U01 DK062444, U01 DK062498, U01-DK62505, U01-DK62536, U01 DK062531, U01-DK62467, U01-DK85563, U01-DK62444, U01 DK062536, U01 DK062496, U01 DK085563, U01 DK085587, U01 DK062467, U01 DK062483, U01-DK62483, U01 DK062494, U01-DK62496, U01-DK62531, U01-DK62484, U01 DK062505, U01-DK62494, U01-DK62498, U01 DK062484, U01-DK85515, U01-DK85587] Funding Source: Medline

Ask authors/readers for more resources

Objectives: To compare long-term survival of living donor liver transplant (LDLT) at experienced transplant centers with outcomes of deceased donor liver transplant and identify key variables impacting patient and graft survival. Background: TheAdult-to-Adult LivingDonor Liver TransplantationCohort Study is a prospective multicenter National Institutes of Health study comparing outcomes of LDLT and deceased donor liver transplant and associated risks. Methods: Mortality and graft failure for 1427 liver recipients (963 LDLT) enrolled in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study who received transplant between January 1, 1998, and January 31, 2014, at 12 North American centers with median follow-up 6.7 years were analyzed using Kaplan-Meier and multivariable Cox models. Results: Survival probability at 10 years was 70% for LDLT and 64% for deceased donor liver transplant. Unadjusted survival was higher with LDLT (hazard ratio = 0.76, P = 0.02) but attenuated after adjustment (hazard ratio = 0.98, P = 0.90) as LDLT recipients had lower mean model for end-stage liver disease (15.5 vs 20.4) and fewer received transplant from intensive care unit, were inpatient, on dialysis, were ventilated, or with ascites. Posttransplant intensive care unit days were less for LDLT recipients. For all recipients, female sex and primary sclerosing cholangitis were associated with improved survival, whereas dialysis and older recipient/donor age were associated with worse survival. Higher model for end-stage liver disease score was associated with increased graft failure. Era of transplantation and type of donated lobe did not impact survival in LDLT. Conclusions: LDLT provides significant long-term transplant benefit, resulting in transplantation at a lower model for end-stage liver disease score, decreased death on waitlist, and excellent posttransplant outcomes. Recipient diagnosis, disease severity, renal failure, and ages of recipient and donor should be considered in decision making regarding timing of transplant and donor options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available